ApoE and CYP2D6 polymorphism with and without parkinsonism-dementia complex in the people of Chamorro, Guam

Neurology

Volumn 47, Issue 3, 1996, Pages 779-784

  Chen, X ^a,c   Xia, Y ^b   Gresham, L S ^c   Molgaard, C A ^b   Thomas, E G ^c   Galasko, D ^b   Wiederholt, W C ^a   Saitoh, T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN DIEGO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENETIC POLYMORPHISM; GENETIC RISK; GUAM; HUMAN; HUMAN CELL; NEUROFIBRILLARY TANGLE; PARKINSON DISEASE; PRIORITY JOURNAL;

EID: 0029817869     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.47.3.779     Document Type: Article

References (40)

1. Spencer PS, Kisby GE, Ross SM, et al. Guam ALS-PDC: possible causes [letter; comment]. Science 1993;262:825-826.
2. Garruto R. Pacific paradigms of environmentally-induced neurological disorders: clinical, epidemiological and molecular perspectives. Neurotoxicology 1991;12:347-377.
3. Gresham LS, Molgaard CA, Smith RA. Induction of cytochrome P-450 enzymes via tobacco smoke: a potential mechanism for developing resistance to environmental toxins as related to parkinsonism and other neurologic diseases. Neuroepidemiology 1993;12:114-116.
4. Gough AC, Smith CA, Howell SM, Wolf CR, Bryant SP, Spurr NK. Localization of the CYP2D gene locus to human chromosome 22q13.1 by polymerase chain reaction, in situ hybridization, and linkage analysis. Genomics 1993;15:430-432.
5. Smith CAD, Gough AC, Leigh PN, et al. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet 1992;339:1375-1377.
6. Kondo I, Kanazawa I. Debrisoquine hydroxylase and Parkinson's disease. Adv Neurol 1993;60:338-342.
7. Armstrong M, Daly AK, Cholerton S, Bateman DN, Idle JR. Mutant debrisoquine hydroxylation genes in Parkinson's disease. Lancet 1992;339:1017-1018.
8. 450 CYP2D6 allelic frequencies in Parkinson's disease. Am J Med Genet (Neuropsych Genet) 1993;48:166-168.
9. Fonne-Pfister R, Bargetzi MJ, Meyer UA. MPTP, the neurotoxin inducing Parkinson's disease, is a potent competitive inhibitor of human and rat cytochrome P450 isozymes (P450bufl, P450dbl) catalyzing debrisoquine 4-hydroxylation. Biochem Biophys Res Commun 1987;148:1144-1150.
10. Collins MA, Neafsey EJ. ß-Carboline analogues of Af-methyl4-phenyl-l,2,5,6-tetrahydropyridine (MPTP): endogenous factors underlying idiopathic parkinsonism? Neurosci Lett 1985; 55:179-184.
11. Roses AD. Apolipoprotein E affects the rate of Alzheimer disease expression: ß-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease. J Neuropathol Exp Neurol 1994;53:429-437.
12. Galasko D, Saitoh T, Xia Y, et al. The apolipoprotein E allele e4 is over-represented in patients with the Lewy body variant of Alzheimer's disease. Neurology 1994;44:1950-1951.
13. Ma J, Yee A, Brewer HB Jr, Das S, Potter H. Amyloidassociated proteins cij-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer ß-protein into filaments. Nature 1994;372:92-94.
14. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high avidity binding to ß-amyloid and increased frequency of type 4 allele in late onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993;90:1977-1981.
15. Wisniewski T, Golabek A, Matsubara E, Ghiso J, Frangione B. Apolipoprotein E: binding to soluble Alzheimer's ß-amyloid. Biochem Biophys Res Commun 1993;192:359-365.
16. Sanan DA, Weisgraber KH, Russell SJ, et al. Apolipoprotein E associates with amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoES. J Clin Invest 1994;2:860-869.
17. Hansen LA, Galasko D, Samuel W, Xia Y, Chen X, Saitoh T. Apolipoprotein-E e4 is associated with increased neurofibrillary pathology in the Lewy body variant of Alzheimer disease. Neurosci Lett 1994;182:63-65.
18. Strittmatter WJ, Weisgraber KH, Goedert M, et al. Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Exp Neurol 1994;125:163-171.
19. Hof PR, Nimchinsky EA, Buee-Scherrer V, et al. Amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam: quantitative neuropathology, immunohistochemical analysis of neuronal vulnerability, and comparison with related neurodegenerative disorders. Acta Neuropathol 1994;88:397-404.
20. Waring SC, O'Brien PC, Kurland LT, et al. Apolipoprotein E allele in Chamorros with amyotrophic lateral sclerosis/parkinsonism-dementia complex. Lancet 1994;343:611.
21. Teng EL, Hasegawa K, Homma A, et al. A practical test for cross-cultural epidemiological studies of dementia: the cognitive abilities screening instrument (CASI). In: Orimo H, Fukuchi Y, Kuramoto K, Iriki M, eds. New horizons in aging science. Tokyo: Tokyo Press,/1992:326-327.
22. Teng EL, Hasegawa K, Homma A, et al. The Cognitive Abilities Screening Instrument (CASI): a practical test for crosscultural epidemiological studies of dementia. Int Psychogeriatr 1994;6:45-58.
23. Fahn S. Scientific approaches to clinical neurology. Philadelphia: Lea & Febiger, 1977:1159-1189.
24. Fahn S, Elton RL, Committee UD. Unified Parkinson's Rating Scale. In: Marsden CD, Calne D, Goldstein M, eds. Recent developments in Parkinson's disease. Florham Park, NJ: Macmillan Healthcare Information, 1987:153.
25. McKhann G, Drachman D, Folstein M, Katzman R, Proce D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Groups under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
26. American Psychiatric Association Task Force on Nomenclature and Statistics. Diagnostic and statistical manual of mental disorders, fourth edition (DSM-IV). Washington, DC: American Psychiatric Association, 1994.
27. Plato CC, Cruz M. Blood group and haptoglobin frequencies of the Chamorros of Guam. Am J Hum Genet 1967;19:722-731.
28. Panserai S, Mura C, Gérard N, et al. DNA haplotypedependent differences in the amino acid sequence of debrisoquine 4-hydroxylase (CYP2D6): evidence for two major allozymes in extensive metabolisers. Hum Genet 1994;94:401-406.
29. Wenham PR, Sedky A, Spooner RJ. Apolipoprotein E phenotyping: a word of caution. Ann Clin Biochem 1991;28:599-605.
30. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1991;31:545-548.
31. Saitoh T, Xia Y, Chen X, et al. The CYP2D6B mutant allele is overrepresented in the Lewy body variant of Alzheimer's disease. Ann Neurol 1995;37:110-112.
32. Tsuneoka Y, Matsuo Y, Iwahashi K, Takeuchi H, Ichikawa Y. A novel cytochrome P-450IID6 mutant gene associated with Parkinson's disease. J Biochem 1993;114:263-266.
33. Armstrong M, Idle JR, Daly AK. A polymorphic Cfol site in exon 6 of the human cytochrome P450 CYP2D6 gene detected by the polymerase chain reaction. Hum Genet 1993;91:616617.
34. Corder EH, Saunders AM, Risch NJ, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet 1994;7:180-184.
35. Daly AK, Armstrong M, Monkman SC, Idle ME, Idle JR. Genetic and metabolic criteria for the assignment of debrisoquine 4-hydroxylation (cytochrome P4502D6) phenotypes. Pharmacogenetics 1991;1:33-41.
36. Hallman DM, Boerwinkle E, Saha N, et al. The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Genet 1991;49:338-349.
37. Gajra B, Candlish JK, Saha N, Mak JW, Tay JSH. Effect of apolipoprotein E variants on plasma lipids and apolipoproteins in the Orang Asli ('aborigines') of Malaysia. Hum Hered 1994;44:209-213.
38. Maestre G, Ottman R, Stern Y, et al. Apolipoprotein E and Alzheimer's disease: ethnic variation in genotypic risks. Ann Neurol 1995;37:254-259.
39. Love S, Saitoh T, Quijada S, Cole G, Terry RD. Alz-50, ubiquitin and tau immunoreactivity of neurofibrillary tangles, Pick bodies and Lewy bodies. J Neuropathol Exp Neurol 1988; 47:393-405.
40. Baum L, Masliah E, limoto DS, Hansen LA, Halliday WC, Saitoh T. Casein kinase is associated with neurofibrillary tangles but is not an intrinsic component of paired helical filaments. Brain Res 1992;573:126-132.